Status | Study |
Recruiting |
Study Name: Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors Condition: Malignant Peripheral Nerve Sheath Tumors Date: 2017-04-13 |
Not yet recruiting |
Study Name: Response Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging Condition: Vestibular Schwannoma Date: 2017-03-20 |
Recruiting |
Study Name: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors Condition: Neurofibromatosis 2 Vestibular Schwannoma Date: 2017-03-08 Interventions: Drug: Selumetinib Continuous twice daily dosing; oral agent |
Not yet recruiting |
Study Name: Study of Aspirin in Patients With Vestibular Schwannoma Condition: Vestibular Schwannoma Acoustic Neuroma Date: 2017-03-06 Interventions: Drug: Aspirin Twice daily aspi |
Not yet recruiting |
Study Name: Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery Condition: Acoustic Neuroma Date: 2017-02-15 Interventions: Other: Testing of Pre-Positioning Frame Placement of bone screws, CT scanning, Surgical planning, Robot |
Recruiting |
Study Name: Familial Investigations of Childhood Cancer Predisposition Condition: Acute Leukemia Adenomatous Polyposis Adrenocortical Carcin Date: 2017-02-08 |
Recruiting |
Study Name: Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery Condition: Metastatic Angiosarcoma Metastatic Epithelioid Sarcoma Met Date: 2016-12-05 Interventions: Drug: Doxorubicin Given IV |
Terminated |
Study Name: Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma Condition: CNS Tumor Date: 2016-11-22 Interventions: Drug: Antineoplaston therapy (Atengenal + Astugenal) Adults with a recurrent/residual Neurofibroma or Sc |
Not yet recruiting |
Study Name: Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors Condition: Peripheral Nerve Tumors Date: 2016-11-21 Interventions: Drug: CPI-0610 Optional tu |
Completed |
Study Name: Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma Condition: Vestibular Schwannoma Date: 2016-11-01 Interventions: Drug: gentamicin intratympanic application of gentamicin 2m/80mg - 3x application -0,5 ml |